Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective-an Analysis of 2846 Patients Across 13 Countries.

Garrido-Cumbrera M, Poddubnyy D, Gossec L, Gálvez-Ruiz D, Bundy C, Mahapatra R, Makri S, Christen L, Delgado-Domínguez CJ, Sanz-Gómez S, Plazuelo-Ramos P, Navarro-Compán V; EMAS Working Group.

Curr Rheumatol Rep. 2019 Mar 12;21(5):19. doi: 10.1007/s11926-019-0819-8. Review.

PMID:
30868287
2.

Added value of biomarkers compared with clinical parameters for the prediction of radiographic spinal progression in axial spondyloarthritis.

Rademacher J, Tietz LM, Le L, Hartl A, Hermann KA, Sieper J, Mansmann U, Rudwaleit M, Poddubnyy D.

Rheumatology (Oxford). 2019 Mar 4. pii: kez025. doi: 10.1093/rheumatology/kez025. [Epub ahead of print]

PMID:
30830164
3.

Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care.

Poddubnyy D, Callhoff J, Spiller I, Listing J, Braun J, Sieper J, Rudwaleit M.

RMD Open. 2018 Dec 5;4(2):e000825. doi: 10.1136/rmdopen-2018-000825. eCollection 2018.

4.

Detection of Sacroiliitis by Short-tau Inversion Recovery and T2-weighted Turbo Spin Echo Sequences: Results from the SIMACT Study.

Greese J, Diekhoff T, Sieper J, Schwenke C, Makowski MR, Poddubnyy D, Hamm B, Hermann KGA.

J Rheumatol. 2019 Jan 15. pii: jrheum.171425. doi: 10.3899/jrheum.171425. [Epub ahead of print]

PMID:
30647167
5.

Progression of Structural Damage in the Sacroiliac Joints in Patients With Early Axial Spondyloarthritis During Long-Term Anti-Tumor Necrosis Factor Treatment: Six-Year Results of Continuous Treatment With Etanercept.

Rios Rodriguez V, Hermann KG, Weiß A, Listing J, Haibel H, Althoff C, Proft F, Behmer O, Sieper J, Poddubnyy D.

Arthritis Rheumatol. 2019 Jan 9. doi: 10.1002/art.40786. [Epub ahead of print]

PMID:
30625261
6.

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study.

Braun J, Baraliakos X, Deodhar A, Poddubnyy D, Emery P, Delicha EM, Talloczy Z, Porter B.

Rheumatology (Oxford). 2018 Dec 19. doi: 10.1093/rheumatology/key375. [Epub ahead of print]

PMID:
30590813
7.

Susceptibility-weighted MR imaging to improve the specificity of erosion detection: a prospective feasibility study in hand arthritis.

Ulas ST, Diekhoff T, Hermann KGA, Poddubnyy D, Hamm B, Makowski MR.

Skeletal Radiol. 2018 Dec 18. doi: 10.1007/s00256-018-3116-0. [Epub ahead of print]

PMID:
30564856
8.

Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors.

Deodhar A, Poddubnyy D, Pacheco-Tena C, Salvarani C, Lespessailles E, Rahman P, Järvinen P, Sanchez-Burson J, Gaffney K, Lee EB, Krishnan E, Santisteban S, Li X, Zhao F, Carlier H, Reveille JD; COAST-W Study Group.

Arthritis Rheumatol. 2018 Oct 20. doi: 10.1002/art.40753. [Epub ahead of print]

PMID:
30343531
9.

Ultra-low-dose CT detects synovitis in patients with suspected rheumatoid arthritis.

Diekhoff T, Ulas ST, Poddubnyy D, Schneider U, Hermann S, Biesen R, Burmester GR, Hamm B, Hermann KG.

Ann Rheum Dis. 2019 Jan;78(1):31-35. doi: 10.1136/annrheumdis-2018-213904. Epub 2018 Sep 29.

10.

An explorative study on deep profiling of peripheral leukocytes to identify predictors for responsiveness to anti-tumour necrosis factor alpha therapies in ankylosing spondylitis: natural killer cells in focus.

Schulte-Wrede U, Sörensen T, Grün JR, Häupl T, Hirseland H, Steinbrich-Zöllner M, Wu P, Radbruch A, Poddubnyy D, Sieper J, Syrbe U, Grützkau A.

Arthritis Res Ther. 2018 Aug 29;20(1):191. doi: 10.1186/s13075-018-1692-y.

11.

Improved detection of erosions in the sacroiliac joints on MRI with volumetric interpolated breath-hold examination (VIBE): results from the SIMACT study.

Diekhoff T, Greese J, Sieper J, Poddubnyy D, Hamm B, Hermann KA.

Ann Rheum Dis. 2018 Nov;77(11):1585-1589. doi: 10.1136/annrheumdis-2018-213393. Epub 2018 Aug 10.

PMID:
30097454
12.

[Advances in research on axial spondyloarthritis].

Rademacher J, Poddubnyy D.

Z Rheumatol. 2018 Sep;77(7):609-612. doi: 10.1007/s00393-018-0517-3. German. No abstract available.

PMID:
30069739
13.

Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.

Proft F, Poddubnyy D.

Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):129-139. doi: 10.1177/1759720X18773726. Epub 2018 May 17. Review.

14.

Response to 'A missing pebble in the mosaic of rheumatic diseases and mental health: younger does not always mean happier' by Alunno et al.

Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D.

Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213620. doi: 10.1136/annrheumdis-2018-213620. [Epub ahead of print] No abstract available.

PMID:
29853451
15.

Radiographic progression in non-radiographic axial spondyloarthritis.

Protopopov M, Poddubnyy D.

Expert Rev Clin Immunol. 2018 Jun;14(6):525-533. doi: 10.1080/1744666X.2018.1477591. Epub 2018 May 24.

PMID:
29774755
16.

[Biomarkers and imaging for diagnosis and stratification of rheumatoid arthritis and spondylarthritis in the BMBF consortium ArthroMark].

Häupl T, Skapenko A, Hoppe B, Skriner K, Burkhardt H, Poddubnyy D, Ohrndorf S, Sewerin P, Mansmann U, Stuhlmüller B, Schulze-Koops H, Burmester GR.

Z Rheumatol. 2018 May;77(Suppl 1):16-23. doi: 10.1007/s00393-018-0458-x. Review. German.

PMID:
29691690
17.

Restless legs syndrome is a relevant comorbidity in patients with inflammatory bowel disease.

Becker J, Berger F, Schindlbeck KA, Poddubnyy D, Koch PM, Preiß JC, Siegmund B, Marzinzik F, Maul J.

Int J Colorectal Dis. 2018 Jul;33(7):955-962. doi: 10.1007/s00384-018-3032-8. Epub 2018 Apr 3.

PMID:
29610943
18.

Hypogalactosylation of immunoglobulin G in rheumatoid arthritis: relationship to HLA-DRB1 shared epitope, anticitrullinated protein antibodies, rheumatoid factor, and correlation with inflammatory activity.

Schwedler C, Häupl T, Kalus U, Blanchard V, Burmester GR, Poddubnyy D, Hoppe B.

Arthritis Res Ther. 2018 Mar 14;20(1):44. doi: 10.1186/s13075-018-1540-0.

19.

Determinants of psychological well-being in axial spondyloarthritis: an analysis based on linked claims and patient-reported survey data.

Redeker I, Hoffmann F, Callhoff J, Haibel H, Sieper J, Zink A, Poddubnyy D.

Ann Rheum Dis. 2018 Jul;77(7):1017-1024. doi: 10.1136/annrheumdis-2017-212629. Epub 2018 Mar 10.

20.

Emerging drugs for the treatment of axial spondyloarthritis.

Rademacher J, Poddubnyy D.

Expert Opin Emerg Drugs. 2018 Mar;23(1):83-96. doi: 10.1080/14728214.2018.1445719. Epub 2018 Mar 1. Review.

PMID:
29475394
21.

Challenges and Advances in Targeting Remission in Axial Spondyloarthritis.

Baraliakos X, Berenbaum F, Favalli EG, Olivieri I, Ostendorf B, Poddubnyy D, DE Vlam K.

J Rheumatol. 2018 Feb;45(2):153-157. doi: 10.3899/jrheum.170222. No abstract available.

22.

Functional relevance of radiographic spinal progression in axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.

Poddubnyy D, Listing J, Haibel H, Knüppel S, Rudwaleit M, Sieper J.

Rheumatology (Oxford). 2018 Apr 1;57(4):703-711. doi: 10.1093/rheumatology/kex475.

PMID:
29373733
23.

Hematopoietic and mesenchymal stem cells: a promising new therapy for spondyloarthritis?

Rios Rodriguez V, Llop M, Poddubnyy D.

Immunotherapy. 2017 Sep;9(11):899-911. doi: 10.2217/imt-2017-0034. Review.

PMID:
29338611
24.

Relevance of structural damage in the sacroiliac joints for the functional status and spinal mobility in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.

Protopopov M, Sieper J, Haibel H, Listing J, Rudwaleit M, Poddubnyy D.

Arthritis Res Ther. 2017 Oct 24;19(1):240. doi: 10.1186/s13075-017-1453-3.

25.

What is the best treatment target in axial spondyloarthritis: tumour necrosis factor α, interleukin 17, or both?

Poddubnyy D, Sieper J.

Rheumatology (Oxford). 2017 Oct 12. doi: 10.1093/rheumatology/kex361. [Epub ahead of print]

PMID:
29040753
26.

Chronic meningococcaemia-a medical oxymoron.

Rademacher J, Haibel H, Poddubnyy D, Ignatius R, Schneider T.

Rheumatology (Oxford). 2017 Oct 1;56(10):1819-1821. doi: 10.1093/rheumatology/kex219. No abstract available.

PMID:
28957545
27.

Tumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.

Rios Rodriguez V, Poddubnyy D.

Ther Adv Musculoskelet Dis. 2017 Aug;9(8):197-210. doi: 10.1177/1759720X17706454. Epub 2017 May 9. Review.

28.

Mechanism of New Bone Formation in Axial Spondyloarthritis.

Poddubnyy D, Sieper J.

Curr Rheumatol Rep. 2017 Sep;19(9):55. doi: 10.1007/s11926-017-0681-5. Review.

PMID:
28752489
29.

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.

Smolen JS, Schöls M, Braun J, Dougados M, FitzGerald O, Gladman DD, Kavanaugh A, Landewé R, Mease P, Sieper J, Stamm T, Wit M, Aletaha D, Baraliakos X, Betteridge N, Bosch FVD, Coates LC, Emery P, Gensler LS, Gossec L, Helliwell P, Jongkees M, Kvien TK, Inman RD, McInnes IB, Maccarone M, Machado PM, Molto A, Ogdie A, Poddubnyy D, Ritchlin C, Rudwaleit M, Tanew A, Thio B, Veale D, Vlam K, van der Heijde D.

Ann Rheum Dis. 2018 Jan;77(1):3-17. doi: 10.1136/annrheumdis-2017-211734. Epub 2017 Jul 6. Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472.

30.

Serum levels of leptin and high molecular weight adiponectin are inversely associated with radiographic spinal progression in patients with ankylosing spondylitis: results from the ENRADAS trial.

Hartl A, Sieper J, Syrbe U, Listing J, Hermann KG, Rudwaleit M, Poddubnyy D.

Arthritis Res Ther. 2017 Jun 15;19(1):140. doi: 10.1186/s13075-017-1350-9.

32.

Comparison of MRI with radiography for detecting structural lesions of the sacroiliac joint using CT as standard of reference: results from the SIMACT study.

Diekhoff T, Hermann KG, Greese J, Schwenke C, Poddubnyy D, Hamm B, Sieper J.

Ann Rheum Dis. 2017 Sep;76(9):1502-1508. doi: 10.1136/annrheumdis-2016-210640. Epub 2017 Mar 10.

PMID:
28283515
33.

Axial spondyloarthritis.

Sieper J, Poddubnyy D.

Lancet. 2017 Jul 1;390(10089):73-84. doi: 10.1016/S0140-6736(16)31591-4. Epub 2017 Jan 20. Review.

PMID:
28110981
34.

Radiographic Evaluation of Sacroiliac Joints in Axial Spondyloarthritis - Still Worth Performing?

Poddubnyy D.

J Rheumatol. 2017 Jan;44(1):1-3. doi: 10.3899/jrheum.161232. No abstract available.

PMID:
28042123
35.

Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.

Poddubnyy D, Fedorova A, Listing J, Haibel H, Baraliakos X, Braun J, Sieper J.

J Rheumatol. 2016 Dec;43(12):2142-2148. Epub 2016 Nov 1.

PMID:
27803139
36.

High disease activity according to the Ankylosing Spondylitis Disease Activity Score is associated with accelerated radiographic spinal progression in patients with early axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort.

Poddubnyy D, Protopopov M, Haibel H, Braun J, Rudwaleit M, Sieper J.

Ann Rheum Dis. 2016 Dec;75(12):2114-2118. doi: 10.1136/annrheumdis-2016-209209. Epub 2016 Apr 28.

PMID:
27125522
37.

New evidence on the management of spondyloarthritis.

Sieper J, Poddubnyy D.

Nat Rev Rheumatol. 2016 May;12(5):282-95. doi: 10.1038/nrrheum.2016.42. Epub 2016 Apr 7. Review.

PMID:
27052489
39.

Golimumab for treatment of axial spondyloarthritis.

Rios Rodriguez V, Poddubnyy D.

Immunotherapy. 2016 Feb;8(2):107-15. doi: 10.2217/imt.15.112. Epub 2016 Jan 22. Review.

PMID:
26798943
40.

Etanercept for the treatment of non-radiographic axial spondyloarthritis.

Rios Rodriguez V, Poddubnyy D.

Expert Rev Clin Immunol. 2016;12(5):493-500. doi: 10.1586/1744666X.2016.1144472. Epub 2016 Feb 24. Review.

PMID:
26788837
41.

Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group.

Lambert RG, Bakker PA, van der Heijde D, Weber U, Rudwaleit M, Hermann KG, Sieper J, Baraliakos X, Bennett A, Braun J, Burgos-Vargas R, Dougados M, Pedersen SJ, Jurik AG, Maksymowych WP, Marzo-Ortega H, Østergaard M, Poddubnyy D, Reijnierse M, van den Bosch F, van der Horst-Bruinsma I, Landewé R.

Ann Rheum Dis. 2016 Nov;75(11):1958-1963. doi: 10.1136/annrheumdis-2015-208642. Epub 2016 Jan 14. Review.

PMID:
26768408
42.

Old and new treatment targets in axial spondyloarthritis.

Rios Rodriguez V, Poddubnyy D.

RMD Open. 2015 Aug 15;1(Suppl 1):e000054. doi: 10.1136/rmdopen-2015-000054. eCollection 2015. Review.

43.

Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial.

Song IH, Hermann KG, Haibel H, Althoff CE, Poddubnyy D, Listing J, Weiß A, Freundlich B, Lange E, Rudwaleit M, Sieper J.

Semin Arthritis Rheum. 2016 Feb;45(4):404-10. doi: 10.1016/j.semarthrit.2015.08.005. Epub 2015 Sep 4.

PMID:
26519007
45.

Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.

Pedersen SJ, Poddubnyy D, Sørensen IJ, Loft AG, Hindrup JS, Thamsborg G, Asmussen K, Hendricks O, Nørregaard J, Piil AD, Møller JM, Jurik AG, Balding L, Lambert RG, Sieper J, Østergaard M.

Arthritis Rheumatol. 2016 Feb;68(2):418-29. doi: 10.1002/art.39434.

46.

Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS).

Sieper J, Listing J, Poddubnyy D, Song IH, Hermann KG, Callhoff J, Syrbe U, Braun J, Rudwaleit M.

Ann Rheum Dis. 2016 Aug;75(8):1438-43. doi: 10.1136/annrheumdis-2015-207897. Epub 2015 Aug 4.

PMID:
26242443
48.

Development of an ASAS-endorsed recommendation for the early referral of patients with a suspicion of axial spondyloarthritis.

Poddubnyy D, van Tubergen A, Landewé R, Sieper J, van der Heijde D; Assessment of SpondyloArthritis international Society (ASAS).

Ann Rheum Dis. 2015 Aug;74(8):1483-7. doi: 10.1136/annrheumdis-2014-207151. Epub 2015 May 19. Review.

49.

Spontaneous, drug-induced, and drug-free remission in peripheral and axial spondyloarthritis.

Poddubnyy D, Gensler LS.

Best Pract Res Clin Rheumatol. 2014 Oct;28(5):807-18. doi: 10.1016/j.berh.2014.10.005. Epub 2014 Nov 10. Review.

50.

Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression.

Syrbe U, Callhoff J, Conrad K, Poddubnyy D, Haibel H, Junker S, Frommer KW, Müller-Ladner U, Neumann E, Sieper J.

Arthritis Rheumatol. 2015 Mar;67(3):678-85. doi: 10.1002/art.38968.

Supplemental Content

Loading ...
Support Center